Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|June 22, 2011
New nitric oxide or hydrogen sulfide releasing aspirinsLoretta Lazzarato, Konstantin Chegaev, Elisabetta Marini, et al.
Molecules (Basel, Switzerland)|December 11, 2022
N-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/DeactivationEleonora Gianquinto, Federica Sodano, Barbara Rolando, et al.
Journal of Medicinal Chemistry|May 12, 2006
NO-donor phenols: a new class of products endowed with antioxidant and vasodilator propertiesDonatella Boschi, Gian Cesare Tron, Loretta Lazzarato, et al.
Bioorganic & Medicinal Chemistry|January 7, 2012
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugsBarbara Rolando, Andrea Filieri, Konstantin Chegaev, et al.
Chirality|April 25, 2006
Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomersKonstantin Chegaev, Loretta Lazzarato, Gian Cesare Tron, et al.
Journal of Medicinal Chemistry|August 6, 2010
Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoproteinRoberta Fruttero, Marco Crosetti, Konstantin Chegaev, et al.
Journal of Medicinal Chemistry|June 22, 2010
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirinsLoretta Lazzarato, Monica Donnola, Barbara Rolando, et al.
Bioorganic & Medicinal Chemistry|July 16, 2014
Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agentsKonstantin Chegaev, Loretta Lazzarato, Yasinalli Tamboli, et al.
Investigational New Drugs|April 3, 2018
New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluationsElisabetta Bigagli, Cristina Luceri, Maria De Angioletti, et al.
Cellular and Molecular Life Sciences : CMLS|November 16, 2018
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcomaIlaria Buondonno, Elena Gazzano, Elisa Tavanti, et al.
Pageof 6